Document is current
Any future updates will be listed below
-
Authors
Li, Yunsong
Wang, Xiaoling
Liao, Yufang
Zeng, Yanbin
Lin, Wanlong
Zhuang, Wei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82304629)
Natural Science Foundation of Xiamen Municipality (3502Z202371048)
- License Information
-
More Information
Article History
Received: 3 February 2024
Accepted: 22 April 2024
First Online: 9 May 2024
Declarations
:
: FDA Adverse Event Reporting System is a spontaneous reporting system, the publicly available data are anonymized, and therefore, obtaining consent to participate is not applicable. The present pharmacovigilance study was conducted using a public database of spontaneous reports. Given the use of deidentified data, ethical approval was not considered necessary.
: Not applicable.
: The authors declare no competing interests.
